Stay updated on Olaparib in Metastatic Prostate Cancer (PROfound Study) Clinical Trial
Sign up to get notified when there's something new on the Olaparib in Metastatic Prostate Cancer (PROfound Study) Clinical Trial page.

Latest updates to the Olaparib in Metastatic Prostate Cancer (PROfound Study) Clinical Trial page
- CheckyesterdayChange DetectedThe revision history now shows a new latest revision (v3.5.5) replacing v3.5.4, indicating a metadata update to the record. No study data or results appear to be altered by this revision.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedA new Revision: v3.5.4 entry was added to the study record history. The previous Revision: v3.5.3 entry was removed from the history.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page now displays an updated ClinicalTrials.gov interface/revision identifier (from v3.5.2 to v3.5.3) without indicating any changes to the underlying study record details.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 on the history page.SummaryDifference0.1%

- Check80 days agoChange DetectedThe revision tag was updated to v3.5.0, replacing the previous v3.4.3 entry.SummaryDifference0.1%

- Check95 days agoChange DetectedA new revision v3.4.3 was added and the previous revision v3.4.2 was removed from the history.SummaryDifference0.1%

Stay in the know with updates to Olaparib in Metastatic Prostate Cancer (PROfound Study) Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib in Metastatic Prostate Cancer (PROfound Study) Clinical Trial page.